mci-196 has been researched along with Obesity in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inagaki, K; Itoh, M; Kanayama, H; Katada, N; Kato, T; Sawai, Y | 1 |
Awata, T; Hosaka, T; Inukai, K; Katayama, S; Kurihara, S; Nakamoto, H; Neda, T; Ono, H | 1 |
Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
Auwerx, J; Harach, T; Maida, A; Nomura, M; Pols, TW; Schoonjans, K; Watanabe, M | 1 |
Inoue, M; Koike, K; Murakami, K; Nozaki, N; Sugiura, K | 1 |
3 trial(s) available for mci-196 and Obesity
Article | Year |
---|---|
Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome.
Topics: Adult; Aged; Albuminuria; Atherosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Diabetes Complications; Epichlorohydrin; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Imidazoles; Insulin Resistance; Japan; Male; Metabolic Syndrome; Middle Aged; Obesity; Quinolines; Resins, Synthetic; Triglycerides; Weight Loss | 2011 |
Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resins, Synthetic; Treatment Outcome | 2012 |
Colestilan, a new bile acid-sequestering resin, reduces bodyweight in postmenopausal women who have dieted unsuccessfully.
Topics: Appetite Depressants; Bile Acids and Salts; Body Mass Index; Body Weight; Drug Administration Schedule; Eating; Female; Humans; Middle Aged; Obesity; Postmenopause; Treatment Outcome | 2005 |
2 other study(ies) available for mci-196 and Obesity
Article | Year |
---|---|
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins.
Topics: Animals; Anion Exchange Resins; Bile Acids and Salts; Blood Glucose; CHO Cells; Cholic Acids; Colon; Cricetinae; Cricetulus; Diet, High-Fat; Enteroendocrine Cells; Glucagon-Like Peptide 1; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Obesity; Proglucagon; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction | 2012 |